Neuralink, the neurotechnology company co-founded by Elon Musk, has announced its ambition to implant its brain-computer interface devices in human subjects within the next six to twelve months. This development signifies a potential major step forward in the company's long-term goal of restoring lost sensory and motor functions. Previous animal trials have demonstrated the device's ability to interpret brain signals and control external hardware, offering hope for individuals with paralysis or other neurological conditions.
The achievement of human implantation would represent a significant milestone for Neuralink and the broader field of brain-computer interfaces. Success could pave the way for therapies addressing blindness, hearing loss, and severe motor impairments, though ethical considerations and regulatory approvals remain crucial hurdles. The company has been pursuing human trials since receiving FDA authorization for its PRIME study in May 2023, focusing initially on individuals with quadriplegia.
“Neuralink Founder Elon Musk: Visual Implants Within Six Months to a Year”
ababnews.com
The Musk Wire aggregates and deduplicates public feeds; it does not republish articles. Continue to news.google.com to read the reporting in full.